Seeing Is Believing
with an average price target of $26.91. This is a potential upside of $17.41 (183.26%) from yesterday's end of day stock price of $9.5.
Poseida Therapeutics's activity chart (see below) currently has 17 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 4.17% with an average time for these price targets to be met of 232 days.
Most recent stock forecast was given by JUSTIN ZELIN from BTIG on 26-Nov-2024. First documented stock forecast 17-Aug-2020.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 26-Nov-2024
$40
1 years 1 months 15 days ago
(26-Nov-2024)
0/1 (0%)
$31.16 (352.49%)
Buy
Since 18-May-2021
$10
$0.5 (5.26%)
$11
2 years 30 days ago
(11-Dec-2023)
1/6 (16.67%)
$7.15 (250.88%)
928
Buy
Since 01-Feb-2023
$17
2 years 5 months 1 days ago
(09-Aug-2023)
0/2 (0%)
$12.68 (293.52%)
Buy
$30
$27.62 (1160.50%)
$30
4 years 10 months 16 days ago
(25-Feb-2021)
0/3 (0%)
$18.66 (170.66%)
What is PSTX (Poseida Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PSTX (Poseida Therapeutics) with a proven track record?
Which analyst has the current lower performing score on PSTX (Poseida Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PSTX (Poseida Therapeutics)?
Which analyst is the currently most bullish on PSTX (Poseida Therapeutics)?
Which analyst is the currently most reserved on PSTX (Poseida Therapeutics)?